Equine antithymocyte globulin versus Basiliximab for induction immunosuppression in living donor kidney transplantation: efficacy safety and feasibility in low resource setting

Thymoglobulin (anti-thymocyte globulin (rabbit)) - Sanofi

Simulect (basiliximab) - Novartis

Lasantha Seneviratne1; Chanaka Abeyrathne1; Yasini Manikkage1; Chathuri Wickramasekera1; Chinthana Galahitiyawa1; Chamila Pilimatalawwe1

Sep 17, 2026